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Abstract
MicroRNAs (miRNAs) are single-stranded non-coding RNAs that negatively regulate target gene expression through mRNA
cleavage or translational repression. There is mounting evidence that they play critical roles in heart disease. The expression
of known miRNAs in the heart has been studied at length by microarray and quantitative PCR but it is becoming evident
that microRNA isoforms (isomiRs) are potentially physiologically important. It is well known that left ventricular
(patho)physiology is influenced by transmural heterogeneity of cardiomyocyte phenotype, and this likely reflects underlying
heterogeneity of gene expression. Given the significant role of miRNAs in regulating gene expression, knowledge of how
the miRNA profile varies across the ventricular wall will be crucial to better understand the mechanisms governing
transmural physiological heterogeneity. To determinine miRNA/isomiR expression profiles in the rat heart we investigated
tissue from different locations across the left ventricular wall using deep sequencing. We detected significant quantities of
145 known rat miRNAs and 68 potential novel orthologs of known miRNAs, in mature, mature* and isomiR formation. Many
isomiRs were detected at a higher frequency than their canonical sequence in miRBase and have different predicted targets.
The most common miR-133a isomiR was more effective at targeting a construct containing a sequence from the gelsolin
gene than was canonical miR-133a, as determined by dual-fluorescence assay. We identified a novel rat miR-1 homolog
from a second miR-1 gene; and a novel rat miRNA similar to miR-676. We also cloned and sequenced the rat miR-486 gene
which is not in miRBase (v18). Signalling pathways predicted to be targeted by the most highly detected miRNAs include
Ubiquitin-mediated Proteolysis, Mitogen-Activated Protein Kinase, Regulation of Actin Cytoskeleton, Wnt signalling, Calcium
Signalling, Gap junctions and Arrhythmogenic Right Ventricular Cardiomyopathy. Most miRNAs are not expressed in a
gradient across the ventricular wall, with exceptions including miR-10b, miR-21, miR-99b and miR-486.
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Introduction
MicroRNAs (miRNAs) are single-stranded non-coding RNAs
consisting of 18–25 nucleotides (nts) that negatively regulate target
gene expression through mRNA cleavage or translational repres-
sion [1]. In recent years miRNAs have been implicated in the
control of expression of many proteins in development and
pathology. In particular there is mounting evidence that they play
critical roles in diseases of the heart [2–4], and they have great
potential as circulating biomarkers of cardiac damage [5].
The rat heart has provided a useful model for the study of heart
physiology and disease for many years, and this utility has been
extended to investigations into the role of miRNAs. Numerous
recent studies have used the rat heart and rat heart cells to
demonstrate the involvement of miRNAs in ischaemia [6–20],
hypertrophy [21–29], heart failure [30–34], fibrosis [35–38],
apoptosis [6,10,17,39–43], metabolism [44,45], angiogenesis
[11,46–48], drug action [11,15,16,49–51] and arrhythmogenesis
[35,51].
Analysis of sequencing-based miRNA expression data has
revealed that individual miRNAs exist not just as a single
canonical sequence but exhibit a range of sequence variants or
‘isomiRs’ [52–55]. These isomiRs can have additions or trunca-
tions at their 59 or 39 end, or internal single-base differences. The
variation between isomiRs occurs during biogenesis due to
cleavage by the RNaseIII enzymes Dicer and/or Drosha at
alternative sites or post-transcriptional editing. The availability of
the rat whole genome sequence makes it possible to differentiate
isomiRs of a single microRNA from closely related microRNAs
with very similar sequences that originate from separate miRNA
genes, designated ‘a’, ‘b’, etc. (for some microRNAs several genes
exist which result in the same mature sequence and in this case it is
not possible to determine whether specific isomiRs are formed
preferentially from one gene). The distribution of isomiRs
indicates that they are not randomly generated, and may have
(patho)physiological importance [56–58]. Indeed, specific isomiRs
have been shown to be functional and to have target gene
repertoires that differ from those of their corresponding canonical
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miRNAs [59,60]. Recent data suggests the possibility of isomiR-
specific gene targeting in the heart [61,62].
The vast majority of myocardial miRNA expression profiling
studies to date have used microarray technologies or quantitative
PCR (qPCR). Although much useful data has emerged from these
studies, these techniques, like all methodological approaches, have
limitations. Microarrays and qPCR assays are designed to detect
and quantify molecular species that are already known to exist;
novel sequences are not detected. IsomiRs would either be
indistinguishable from the canonical sequence or not detected at
all. The former is likely in microarray-based methods while the
latter could apply in qPCR, depending on the type of isomiR. In
contrast to the aforementioned methods ‘next-generation’ or
‘deep’ sequencing is able to detect and quantify novel sequence
variants as well as those already known. We therefore used next-
generation sequencing to characterise the expression profile of
miRNAs in rat heart left ventricular wall, identify novel miRNAs
and novel orthologs not previously characterised in this species
and determine the relative expression of isomiRs of individual
miRNAs. To our knowledge this is the first report of miRNA deep
sequencing data from rat heart using the Illumina platform. We
detected several novel rat miRNAs and multiple novel isomiRs of
known miRNAs, many of which were detected at a higher
frequency than the corresponding mature sequence recorded in
miRBase [63,64].
The well established heterogeneity of cardiomyocyte physiology
across the left ventricular wall influences both normal heart
function and pathophysiology [65,66] and likely reflects underly-
ing heterogeneous gene expression. Given the significant role of
miRNAs in regulating gene expression, knowledge of how the
miRNA profile varies across the ventricular wall will be crucial to
understand the mechanisms governing transmural physiological
heterogeneity. Data describing transmural miRNA expression is
very limited and we therefore undertook the first comprehensive
determination of miRNA expression profiles at different locations
across the left ventricular wall. We have found that most miRNAs
are not expressed in a gradient across the ventricular wall, with the
exceptions of miR-10b, miR-21, miR-99b and miR-486.
Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health; and the
United Kingdom Animals (Scientific Procedures) Act, 1986. The
protocol was approved by the Animal Research Ethics Committee
of Queen’s University Belfast (Project Licence: PPL 2683).
miRNA Library Preparation
The hearts of 3 male 8 month old Sprague-Dawley rats were
rapidly extracted after euthanasia with sodium pentobarbital. A
section of the free wall of the left ventricle was dissected into
epicardium, mid-myocardium and endocardium by cutting
approximately 1 mm from the epicardial and endocardial
surfaces. Tissue was weighed, chopped, stored in RNAlater
RNA stabilisation reagent (Qiagen, Crawley UK) and then flash
frozen in liquid nitrogen before placing in storage at280uC. Small
RNA was extracted (miRNeasy Kit; Qiagen), quantified (Nano-
drop; Thermo Scientific) and quality assessed for degradation
(RNA Nano Chip, Bioanalyser 2100; Aligent Technologies,
Wokingham UK; only samples with a RNA integrity no. (RIN)
$8 were carried forward) and retention of small RNA (Small
RNA Chip, Bioanalyser 2100). Small RNA was preferentially
ligated with adapters, reverse transcribed into cDNA and
amplified with 9 individually tagged primer indices (TruSeq Small
RNA Sample Preparation Kit; Illumina, Little Chesterford, UK)
and a library of small RNA created for each sample. After gel
purification the cDNA products were again analysed on the
bioanalyser using a High Sensitivity DNA Chip and assessed for
the presence and concentration of the peak corresponding to
ligated and tagged miRNA (approximately 147 nt). It was
Figure 1. Length distribution analysis of small RNA sequences
in 3 mid-myocardial rat samples. Reads greater than 12 nt are
included. Red bars represent reads annotated to known rat miRNAs
(miRBase v18), green bars represent reads annotated to miRNAs in
other species (novel orthologs) and black bars represent unannotated
small RNA sequences.
doi:10.1371/journal.pone.0065809.g001
MicroRNAs in Rat Heart Left Ventricle
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observed that the successful presence of an appropriate end
product was not wholly dependent on the integrity of the initial
RNA sample (RIN; See Fig. S1) but could be better predicted from
the presence or relative absence of a range of small RNA species
(tRNA, 5S and miRNA) assessed on the Small RNA Chip
electropherogram; therefore only samples with suitable RIN values
exhibiting good retention of small RNA species were used for
library preparation. After pooling, the samples were sequenced by
TrinSeq (Trinity Genome Sequencing Lab & Neuropsychiatric
Genetics Group, Trinity College Dublin, Ireland (http://www.
medicine.tcd.ie/sequencing); using TruSeq SR Cluster Kit v5
(Illumina) and the resultant data trimmed and aligned to miRBase
v18 (CLC Genomics Workbench v4.0; CLC bio, Swansea UK).
PCR
Genomic DNA was extracted from rat heart (Direct PCR lysis
reagent; Viagen Biotech Inc, Los Angeles, CA, USA) to form the
template for confirmation of the stem loop sequence for pre-miR-
486 in a PCR reaction using primers (Table S1) designed from a
rat genomic DNA sequence (gnl|ti|1621823597;
gnl|ti|1718641223) not present in the most recent build of the
rat genome (Baylor 3.4), and DreamTaq polymerase (Fermentas).
Cycling parameters were: 95uC for 3 min, 356 (95uC for 30 s,
49uC for 30 s, 72uC for 20 s), 72uC for 15 min. Amplified
products were sequenced (Genomics Core, Queen’s University
Belfast).
Quantitative PCR was carried out using Taqman small RNA
assays and TaqMan gene expression assays (Invitrogen – Life
Technologies Ltd, Paisley, UK) on RNA samples from rat hearts
dissected and extracted as detailed above. REST 2009 software
[67,68] was used to determine the expression ratio between
epicardial and endocardial samples using multiple endogenous
controls which were tested for consistent expression across samples
using BestKeeper [69].
Plasmid Construction
A 102 bp fragment of the human gelsolin sequence (NCBI
Reference: Chromosome 9, NC_000009.11
(124030380.124095120)) was amplified from human genomic
DNA (Bioline, London, UK) by a two-stage nested PCR using
PhusionH Hot Start II High-Fidelity DNA Polymerase (see Table
S1 for primer sequences).
The product was restricted with XhoI and BamHI and ligated
into pmR-mCherry (Clontech, Saint-Germain-en-Laye, France;
modified as described [70]). The final product (pmChGSN) has
the CMV promoter driving transcription of mCherry with the
gelsolin fragment as 39 UTR.
The plasmid pSM30 (encoding EGFP) was used for expression
of miRNAs [71]. Complementary pairs of oligonucleotides
(25 mM) encoding artificial miRNA sequences (miR-133a canon-
ical isomiR and most common isomiR (miR-133a(v))), a siRNA
sequence designed to down regulate mCherry expression (siR-
mCh), or a random non-targeting negative control sequence
(NTC) were annealed and ligated (T4 DNA ligase; New England
Biolabs, Hitchin, UK) into pSM30 restricted with BsmBI (New
England Biolabs, Hitchin, UK). Oligonucleotide sequences are
shown in Table S2.
Following confirmation of inserts by DNA sequencing (Geno-
mics Core, Queen’s University Belfast, UK), plasmids were
prepared with a Maxiprep kit (Qiagen, West Sussex, UK)
following the manufacturer’s instructions. Custom oligonucleotides
were purchased from Eurogentec (Seraing, Belgium).
Dual Fluorescence miRNA Targeting Assay
This assay has been described in detail previously [70].
HEK293 cells were plated into a 24-well plate. The following
day, cells were transiently transfected with pmChGSN, in addition
to one of pSM30miR-133a, pSM30miR-133a(v), pSM30NTC or
pSM30siR-mCh using Turbofect Transfection reagent (Thermo
Scientific, Hemel Hempstead, UK). Cells were imaged at 20X
magnification using a Nikon Eclipse TE2000-U microscope
equipped with a 488 nm filter (red; mCherry fluorescence) and a
550 nm filter (green; EGFP fluorescence). Red and green images
were acquired of multiple fields using NIS Elements software
(Nikon, Badhoevedorp, Netherlands). Cross-channel bleed-
through was found to be negligible by acquiring red images of
cells transfected with pSM30miR-133a only, and green images of
cells transfected with pmChGSN only. These images were then
used for subtraction of background fluorescence. Images in tiff
format were analysed by Volocity software (Volocity 5.5.1,
PerkinElmer Inc., Waltham, MA, USA). We developed a Volocity
Figure 2. miRNA detection frequency. Most highly detected miRNAs grouped on mature sequence, normalised to total annotated reads
(expressed in reads per million mapped (RPMM) from 3 rat mid-myocardial samples).
doi:10.1371/journal.pone.0065809.g002
MicroRNAs in Rat Heart Left Ventricle
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pipeline for identifying cells in green images and measuring the
total red and green intensities of each identified cell. Data were
exported in Microsoft Excel format for further analysis (Prism 4,
GraphPad, San Diego, CA, USA).
Results
Overview of Next Generation Sequencing Data
A total of 2,947,762 reads between 12 and 73 nt in length were
produced by next generation sequencing of the 3 samples of mid-
myocardium (Fig. 1). miRNAs were aligned and grouped on the
mature sequence, allowing for up to 2 mismatches within the
sequence and/or 3 additions or deletions from either the 59 or 39
Figure 3. Frequency of isomiRs with 59 and/or 39 variations. Distributions of 59 (left) and 39 (right) end variants are shown for miRNAs derived
from the 59 arm (A) and from the 39 arm (B) of the pre-miR hairpin. Data are mean 6 SEM for three mid-myocardial samples.
doi:10.1371/journal.pone.0065809.g003
MicroRNAs in Rat Heart Left Ventricle
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ends. This identified 1,782,482 reads that were annotated to
known miRNA sequences from Rattus norvegicus entries in miRBase
v18 and a further 307,672 annotated to miRNA sequences only
previously reported in other species (potentially representing novel
orthologs). The proportions of reads of length .12 representing
known rat miRNAs, potential novel orthologs or not matching any
known miRNA (unannotated) are shown in Fig. 1. In all 3 samples
the median length of reads was 22 nts and 80.7360.20% (mean6
sem) of the reads at this length were annotated to known rat
miRNA sequences. In total, 145 previously characterised rat
miRNA sequences had representation of $10 raw reads prior to
normalisation (Table S3; S3A compiled from miRNAs with $10
raw ‘exact mature’ reads, S3B compiled from miRNAs with ,10
‘exact mature’ reads but $10 ‘grouped on mature’ raw reads) in at
least one of the 3 samples. Using the same criteria a further 68
potential novel orthologs were identified (Table S4). Additionally
all reads of sequences originally reported in miRbase as the minor
strand (*) were grouped (upon similar criteria as above; Table S5)
resulting in a further 58 miRNAs of interest, 16 of which
(including miR-126*, miR-140*, miR-151* and miR-28*) were
detected between 1.23 and 99.56 fold higher in the * form than the
‘major’ mature sequence, while miR-501* was not detected in the
major mature strand form. By combining the 3 sample groups and
normalising to reads per million mapped (RPMM), the most
highly detected miRNAs ($1000 RPMM) were identified (Fig. 2).
miR-22, miR-486, miR133a and miR-143 were detected at
greater than 100,000 RPMM. Twelve miRNAs were detected at
greater than 10,000 RPMM and a further 40 miRNAs were
detected at greater than 1,000 RPMM. Six of the top 56 most
highly detected miRNAs were * sequences. Fifty-three of the top
56 most highly detected miRNAs were previously annotated rat
miRNAs, but the second most highly detected miRNA mapped to
the human miRNA hsa-miR-486-5p and has yet to be registered
in miRBase as a rat miRNA, although Small et al. [72] have shown
it to be highly expressed in rat myocardium. Characterisation of
the rat miR-486 gene is described below.
Individually, miR-22 has been implicated in the phenylephrine-
or angiotensin II-induced hypertrophic reduction in phosphatase
and tensin homolog (PTEN) [24]; miR-26a and 30d in calcium
dependent cardiac dysfunction [73], and miR-27b in heart
development and hypertrophy [74,75]. PTEN and Foxo1a are
known targets of miR-486 [72]. Of particular note in the context
of cardiac physiology, miR-486 is predicted by TargetScan 6.2
(Whitehead Institute for Biomedical Research) to target the
Figure 4. IsomiRs of selected miRNAs. IsomiR sequences of the 10 most highly detected miRNAs (mature miRNA highlighted in yellow) with
expression values in brackets from a mid-myocardial sample aligned to the published pre-miR sequence (boxed in green; miRBase v18). Consensus
sequence (boxed in blue) for each miRNA represents the most prevalent nt aligned at each position (nts highlighted in pink represent variations from
the miRBase published mature sequence).
doi:10.1371/journal.pone.0065809.g004
MicroRNAs in Rat Heart Left Ventricle
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transcription factor IRX5, which negatively regulates Kv4.2 K
+
channel expression [76,77].
Abundance of isomiR Sequences
The frequency of isomiRs with 59 and/or 39 variations from the
canonical (miRBase) sequence is summarised in Fig. 3 for a mid-
myocardial sample. Of the sequences derived from the 59 arm of
the hairpin miRNA, 62.6% varied from the canonical sequence at
the 39 end (with approximately half being longer and half being
shorter), and 3.6% varied at the 59 end (with approximately two-
thirds being shorter). Of the sequences derived from the 39 arm,
50.1% varied from the canonical sequence at the 39 end (with
approximately three-fifths being longer), and 13.8% varied at the
59 end (with a strong bias towards shorter variants). This
distribution is similar to that found in cardiomyocyte-derived
HL-1 cells [61]. The greater 59 end variability in the 3’ arm-
derived compared to 5’ arm-derived miRNAs corresponds with
the previously reported higher fidelity of Drosha vs Dicer cleavage
[78]. Variability at the 3’ end is also influenced by post-cleavage
processing [79,80].
Closer analysis of the top 56 most highly detected miRNAs
revealed that the mature form (or the mature* sequence) of the
miRNA as published in miRBase was not always the most
common sequence encountered. For the top 10 most highly
detected miRNAs, the reads representing the 10 most common
isomiR sequences are illustrated in Fig. 4. For only 4 of these,
miR-22, 486, 26a and 181a, is the annotated mature form the
most highly detected and even for these miRNAs significant
numbers of several other isomiRs were also detected. For example,
while the exact mature sequence of miR-22 constituted
93.0460.35% of its total reads, the exact mature sequence of
miR-181a only constituted 51.0960.59%. Characteristically for
miRNAs, the majority of miR-486 isomiR sequences differed at
the 39 end of the sequences and were shortened mature sequences
(sub) or mature sequences with additional nts (super) matching the
pre-miR sequence. However, substantial populations of reads
exhibited nt substitutions varying from the pre-miR sequence
(compare pre-miR and consensus sequences in Fig. 4B), largely by
the addition of nts at the 39 end, most commonly T’s and A’s.
Analysis of the sequences attributed to miR-143 (Fig. 4D)
showed that the mature sequence was only the 4th most common
sequence, indeed the most common miR-143 sequence is an
isomiR with an unambiguous post-transcriptional modification,
that is a non-templated addition of A at nt no. 22. Additional
significantly expressed variants include nt no. 21 C to T, and nt
no. 23 G to T. As expected, little variation was observed at the 59
end of the majority of the most highly detected miRNAs.
However, miR-378 (Fig. 4G) and the cardiac muscle-enriched
miR-133a are exceptions. As illustrated in Fig. 4C the most
frequently recorded miRNA sequence attributed to miR-133a is
missing nt no. 1; indeed 53.9660.46% of all miR-133a reads are
missing this nt. This truncation could have a profound effect on
target sequence recognition, and therefore the spectrum of target
genes regulated. Indeed, DIANA-microT v3.0 (which accepts
novel miRNA sequences) [81,82] predicts 602 target genes for
canonical miR-133a and 145 for the 59 variant (miR-133a(v)), with
90 genes in common. Gelsolin is among the 55 genes predicted to
be targeted by miR-133a(v) but not by miR-133a itself. We used
the dual-fluorescence miRNA targeting assay [70] to determine
the effects of miR-133a and miR-133a(v) on the expression of a
reporter gene with a 39 gelsolin fragment incorporating the more
conserved of the two predicted miR-133a(v) target sites. Suppres-
sion of the target gene is reported as a decrease in red/green
fluorescence intensity ratio in this assay. Fig. 5 shows that miR-
133a(v) was more effective at suppressing the mCherry-gelsolin
construct than was miR-133a, and was comparable to a siRNA
targeted against the mCherry sequence.
Surprisingly, miR-10b exhibited no exact mature sequences (see
Table S3B); on closer analysis sequences aligned to miR-10b were
found to exhibit shifting in the mature miRNA cleavage position
with 12.3860.77% of the reads including 1 extra nt and
87.3960.91% 2 extra nts from the pre-miR sequence at the 59
end (see Fig. S2). This type of 59 end variation has been attributed
to variability in Drosha cleavage position [83]. The 2 extra 59 nts
give the most abundant isomiR the same seed sequence as rno-
miR-10a-5p, although the rest of the isomiR sequence corresponds
to rno-miR-10b-5p, which has a single internal mismatch
compared to rno-miR-10a-5p. Of 148 target sites in 85 genes
predicted for rno-miR-10a-5p by DIANA-microT v3.0, 147 are
Figure 5. Differential suppression of a gelsolin sequence-
tagged reporter gene by miR-133a isomiRs. HEK293 cells were
transfected with expression plasmids encoding mCherry with a 39
partial gelsolin sequence and pSM30 containing inserts for miR-133a,
miR-133a(v), a random non-targeting sequence (NTC) or siRNA against
mCherry (siR-mCh). Cells were imaged and analysed for both green and
red fluorescence intensity. A decrease in red/green ratio vs NTC
indicates downregulation of target gene expression. Data were log
transformed and compared by one-way ANOVA with Bonferroni’s
Multiple Comparison Test. All pairwise comparisons were significant
(p,.001). Comparison of miR-133a vs miR-133a(v) is indicated (***).
Number of cells (n): miR-133a 4640; miR-133a(v) 2843; NTC 4088; siR-
mCh 3884. Representative of 3 separate experiments in which miR-
133a(v) was significantly more effective than miR-133a.
doi:10.1371/journal.pone.0065809.g005
Figure 6. Relative miRNA abundance by TaqMan assay.
Expression of miRNAs relative to rno-miR-1 according to 22DCt where
DCt = Ct – CtmiR-1 (mean 6 SEM). Ct values were compared by repeated
measures ANOVA and Tukey’s multiple comparison test; **p,.01,
***p,.001. Mid-myocardial samples from n=6 hearts.
doi:10.1371/journal.pone.0065809.g006
MicroRNAs in Rat Heart Left Ventricle
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also predicted for the most frequent miR-10b isomiR, reflecting
the dominance of the seed region in target recognition. In
comparison, only one of the 10 predicted target genes found for
canonical rno-miR-10b is shared with the isomiR.
A Novel Rat miR-1 Analog
It was surprising that miR-1 was only the 28th most abundant
miRNA in the sequencing data (Fig. 2) because it is generally
considered to be one of the most highly expressed in the heart
[84]. It has been demonstrated that observed miRNA abundance
can vary significantly between experimental methods [85]. It is
possible that preferential cloning of certain sequences or differ-
ences in PCR amplification may skew the numbers of reads
representing different miRNAs. Indeed, the RNA adapters used
can introduce sequencing bias through secondary structure
preferences of RNA ligases [86]. The possibility that miR-1 is
under-represented in our libraries is supported by the RT-qPCR
data shown in Fig. 6 which suggests that, based on relative Ct
values, miR-1 is more abundant than miR-22 and miR-486 which
are the two most common miRNAs in the deep sequencing data
(Fig. 2). Another consideration when comparing sequencing and
TaqMan data is the specificity of TaqMan assays for the canonical
mature sequence. For example 57% of miR-486 reads in the
sample shown in Fig. 4 are 39 variants that would not be detected
by TaqMan because of the 39 specificity of the looped RT primer
used in TaqMan small RNA assays.
Notwithstanding the potentially anomalous measure of abun-
dance, the sequencing data enabled us to observe a variant in the
sequence of miR-1; at nt no. 17 an A was frequently present in
place of the G in the pre-miR sequence (77.2361.13% of reads;
Fig. 7A). The G to A substitution gives a sequence equivalent to
hsa-miR-1 (and mmu-miR-1) which has not been reported before
in rat (Fig. 7B). It is unlikely that G could be converted to A by
post-transcriptional editing; therefore we investigated the possibil-
Figure 7. Novel rno-miR-1 sequence as detected by deep sequencing. A: Ten most frequently detected isomiR sequences of miR-1 (rat
mature miRNA highlighted in yellow) with expression values in brackets aligned to the published pre-miR sequence (boxed in green; miRBase v18).
The consensus sequence (boxed in blue) represents the most prevalent nt aligned at each position (nts highlighted in pink represent variations from
the miRBase published mature sequence). B: miR-1 sequences as published in miRBase v18 showing the novel rat miR-1 sequence aligned with the
previously reported rat miR-1 and the human sequence (with which it is identical). C: Predicted stem-loop structure (mFold 3.2) of proposed pre-miR
deduced from genomic sequence. Mature product highlighted in blue.
doi:10.1371/journal.pone.0065809.g007
MicroRNAs in Rat Heart Left Ventricle
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ity that the rat harbours a second miR-1 gene. Although the most
common sequence carrying the A (59-TGGAATGTAAAGAAG-
TATGTAT-39) could not be detected in the latest available build
of the Rattus norvegicus genome (Baylor 3.4), the sequence matched
two rat whole genome shotgun sequences
(gb|AAHX01027125.1|; gb|AABR06028312.1|) which have
not been incorporated into this build. Fig. 7C shows the genomic
context of this novel miRNA and the predicted stem-loop structure
(mFold version 3.2 [87]). This sequence is also present in the rat
heart data set of Linsen et al. [88]. The existence of two rat miR-1
genes has implications for understanding how this important
miRNA is regulated.
A Novel Rat miRNA
Analysis of unannotated reads by the miRanalyser utility [89]
yielded a putative novel miRNA. This miRNA has a mature
sequence similar to mmu-miR-676-3p and hsa-miR-676-3p
(Fig. 8A). The genomic context has a predicted stem-loop structure
at chrX:88378185-88378273 (Ensembl genome ID EN-
SRNOG00000040353) (Fig. 8B).
Cloning and Sequencing of the Rat miR-486 Gene
No pre-miR sequence has been published for miR-486 in rat
and the mature miRNA sequence is not present in the most recent
build of the rat genome (Baylor 3.4). However, alignment of the
mouse pre-miR-486 (MI0003493) sequence revealed a potential
rat pre-miR-486 sequence on chromosome 16:73341164 (reverse
strand) which is truncated just before the end of the potential miR-
486 mature sequence at nt 73341114 by a gap in the genome
sequence. A BLAST search revealed two whole genome shotgun
sequences spanning this gap, allowing the design of PCR primers
that were used to amplify the region from rat genomic DNA. This
enabled confirmation of the sequence of the putative miR-486
gene, which contains a stem-loop sequence matching both mature
miR-486 reads in the 5p arm and observed ‘star’ sequences from
the 3p arm (Fig. 9).
Transmural Distribution of miRNA Expression
Several aspects of cardiomyocyte physiology are known to vary
across the left ventricular wall [66,90–111] and the mechanism
undoubtedly involves differential gene expression. Transmural
expression level is uniform for the vast majority of genes but there
Figure 8. Novel rat miRNA similar to miR-676-3p. A: Alignment of the novel rat miRNA sequence to miR-676-3p sequences as published in
miRBase v18. B: Predicted stem-loop structure (mFold 3.2) of proposed pre-miR deduced from genomic sequence. Mature miRNA highlighted in blue.
doi:10.1371/journal.pone.0065809.g008
Figure 9. The rat miR-486 gene. A: Alignment of the genomic miR-486 sequence across nine species including rat (highlighted in red). Blue
shading indicates percentage sequence identity and the mature and ‘star’ sequences represented by the most common reads are indicated with
arrows. B: Predicted stem-loop structure (mFold 3.2) of pre-miR-486 deduced from genomic sequence. Mature miRNA highlighted in blue.
doi:10.1371/journal.pone.0065809.g009
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are some notable exceptions [112–114]. Given the role of miRNAs
in regulating gene expression it would be useful to determine the
extent of transmural heterogeneity of the expression of miRNAs
themselves. In accordance with other gene expression data [112]
we found the transmural distribution of miRNA expression to be
generally uniform. Nevertheless, differences in relative abundance
were observed between endocardium and epicardium for several
miRNAs (Tables 1, 2, and 3). Some of the more abundantly
detected miRNAs showed some transmural difference that did not
reach statistical significance across the three hearts. We selected
some of these miRNAs for further investigation by qPCR
(TaqMan miRNA assays) in four additional hearts and found
statistically significant (p,.05) transmural expression gradients for
miR-10b, miR-21, miR-99b and miR-486 (Fig. 10). Transmural
expression gradients for IRX5 and FOXP2 were in agreement
with a previous report [112]. Deep sequencing shows a transmural
gradient (epicardium.endocardium) for miR-10b (Table 2,
‘‘grouped on mature’’). As discussed above, this group includes
no canonical miR-10b, with only 5.6% of reads having the
canonical 39 end (4th and 6th in the list in Fig. S2). This could
explain the high Ct values (low abundance) we obtained with the
miR-10b TaqMan assay which is designed to be specific for the
exact 39 end of the canonical sequence. Additionally, sequencing
analysis identified 8 individual sequences within the miR-10a/b
family (unique sequences; Table 3) as having .2 fold detected
difference (epicardium.endocardium) within the samples tested.
Prediction of Signalling Pathway Targets
To reveal the pathways most likely to be significantly regulated
by miRNAs, pathway analysis was performed based upon the top
16 most highly detected miRNA sequences (.10,000 RPMM)
utilizing DIANA LAB (loose, strict and Beta algorithms as well as
TargetScan5 and Pictar [115] combined with TargetScan 6.0
(including poorly conserved sites – Total context score #-0.1) and
Micro-org individual predictions (mirSVR score # -0.3). Exclud-
ing targets which only appeared on one of the 7 prediction lists,
Table 1. Epicardial/endocardial differential expression of exact mature (or mature*) miRNAs ($ 61.5 fold difference for miRs of
$10 raw reads detected in either layer).
Exact mature/*sequences Epi-cardium Endo-cardium
RPMM RPMM
miR name Fold change Mean SEM Mean SEM
rno-mir-31 3.00 4.45 2.62 13.36 3.49
rno-mir-326 1.92%%% 12.52 0.98 24.06 2.03
rno-mir-872 1.80 11.42 2.54 20.61 5.32
rno-mir-1249 1.66 62.40 12.09 103.28 28.92
rno-mir-503* 1.64 5.02 1.45 8.21 0.65
rno-mir-193 1.54 14.14 2.23 21.82 8.28
rno-mir-872* 1.53 51.11 7.20 78.40 14.18
mmu-mir-1983 1.53 8.16 3.02 12.45 2.99
rno-mir-145 1.50 1038.98 188.02 1558.55 346.49
rno-mir-10a 21.51 1967.41 189.80 1305.65 527.54
rno-mir-9-1//mir-9-3//mir-9-2 21.52 64.65 13.48 42.62 11.51
rno-mir-208 21.52 12.33 3.51 8.09 3.41
rno-mir-132 21.61 18.32 1.35 11.37 2.24
rno-mir-138-2//mir-138-1 21.66 17.24 2.76 10.36 4.83
rno-mir-210* 21.69 7.65 1.69 4.53 1.10
rno-mir-100 21.70 2089.07 827.35 1230.28 597.96
rno-mir-133b 21.70 15.27 4.06 8.98 2.54
rno-mir-133a* 21.72 206.39 59.22 120.26 27.43
rno-mir-17-1//mir-17-2 21.81 10.74 1.68 5.93 0.32
rno-mir-322* 21.98 20.39 8.69 10.31 5.30
mmu-mir-720 22.00 23.31 5.27 11.66 1.00
rno-mir-425 22.25 15.66 3.01 6.96 3.58
hsa-mir-720 22.30 39.25 8.00 17.09 2.93
rno-mir-374 22.49 8.51 3.73 3.42 0.66
rno-mir-410 22.88%% 56.31 2.35 19.58 5.31
hsa-mir-4492 22.92 26.70 10.82 9.14 4.45
rno-mir-200b 25.88 13.39 10.25 2.28 1.23
rno-mir-547* 29.73 6.82 3.21 0.70 0.70
%%%P,0.001,
%%P,0.01, Baggerleys multiple comparison test.
doi:10.1371/journal.pone.0065809.t001
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the resultant 2808 genes were compared with a list of genes
expressed in heart (as identified from 9 Sprague-Dawley rat left
ventricular myocardium samples from 2 microarray experiments
published on GEO (GSE6943; GSM160095-100 & GSE6880;
GSM158589-91; http://www.ncbi.nlm.nih.gov/gds)) resulting in
1624 potential targets expressed in and therefore most relevant to
heart. Of the significantly targeted pathways the most relevant to
cardiac physiology and pathophysiology were the Ubiquitin-
mediated Proteolysis pathway (Benjamini corrected
P= 7.1261027; 46 targets), Mitogen-Activated Protein Kinase
Table 2. Epicardial/endocardial differential expression of ’grouped on mature’ miRNAs ($ 61.5 fold difference for miRs of $10
raw reads detected in either layer).
’Grouped on mature’ sequences Epi-cardium Endo-cardium
RPMM RPMM
miR name Fold change Mean SEM Mean SEM
rno-mir-200b 24.26 25.92 16.66 6.08 3.31
rno-mir-410 22.87%%% 70.10 3.37 24.41 5.32
mmu-mir-690 22.55 12.73 3.72 5.00 1.39
rno-mir-10b 22.51%% 3064.12 431.15 1221.18 441.95
mmu-mir-720 22.20 27.78 6.87 12.63 1.12
mmu-mir-351 22.08 11.37 2.93 5.47 0.60
hsa-mir-4485 22.07 9.81 2.27 4.75 1.81
rno-mir-341 22.05 7.78 2.10 3.80 2.45
mmu-mir-5115 21.99 5823.13 1542.50 2930.00 1218.62
rno-mir-384 21.97 8.73 2.79 4.43 1.46
bta-mir-2478 21.96 358.54 67.41 182.69 21.31
hsa-mir-720 21.96 68.26 12.81 34.90 6.30
hsamir-4492 21.92 43.13 13.29 22.46 9.31
cbr-mir-1 21.91 10.46 4.84 5.47 1.06
rno-mir-10a 21.87 30279.72 3036.38 16169.54 6084.64
hsa-mir-1260a 21.77 278.56 53.99 157.62 42.34
rno-mir-338 21.77 117.08 1.79 66.29 7.61
mmu-mir-5102 21.73 11.49 3.65 6.65 1.16
rno-mir-138-2//mir-138-1 21.71 27.70 5.62 16.18 8.01
rno-mir-100 21.70 5514.57 2226.60 3245.17 1552.80
rno-mir-132 21.63 37.90 2.55 23.21 4.82
rno-mir-9-1//mir-9-3//mir-9-2 21.58 169.45 26.81 107.12 26.08
ssc-mir-186 21.57 16.66 5.25 10.60 1.13
dre-mir-26b 21.54 25.55 7.97 16.64 2.29
cte-mir-1 21.53 6.37 1.86 4.17 1.71
gga-mir-3535 21.52%% 9.46 0.21 6.24 1.83
rno-mir-374 21.52 64.17 18.59 42.34 7.63
rno-mir-411 21.50% 39.14 3.72 26.11 4.25
rno-mir-145 1.50 1537.62 272.14 2300.09 506.26
ola-mir-27d 1.50 6.30 1.14 9.42 3.09
gga-mir-193b 1.51 28.48 5.52 42.86 6.54
mmu-mir-101c 1.56 7.32 2.86 11.39 0.42
rno-mir-326 1.57 37.54 1.72 59.00 5.46
bta-mir-1306 1.63 5.20 1.59 8.45 0.66
rno-mir-877 1.64 8.05 1.21 13.20 1.75
sha-mir-716a 1.75 8.22 0.13 14.37 6.10
rno-mir-674 2.15 5.44 0.81 11.67 1.74
rno-mir-31 2.54 9.37 4.26 23.78 6.64
%%%P,0.001.
%%P,0.01,
%P,0.05 Baggerleys multiple comparison test.
doi:10.1371/journal.pone.0065809.t002
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pathway (MAPKinase; P= 1.8661026; 75 targets; Fig. 11),
Regulation of Actin Cytoskeleton (P= 2.2961024; 56 targets),
Wnt pathways (P = 3.4561024; 42 targets), Calcium Signaling
(P= 5.0161024; 49 targets), Gap junctions (P = 6.4361024; 27
targets) and Arrhythmogenic Right Ventricular Cardiomyopathy
pathway (ARVC; P= 0.047; 20 targets).
Further analysis of a shortlist of genes important in contraction,
electrical activity, Ca2+ signalling, cell communication, ion
homeostasis and gene expression showed potential targeting of
components contributing to the generation of INa, ICa,L, IKur, Ito,
IKATP, INaCa, If, IKp as well as SR Ca
2+ re-uptake and contraction
(see Table S6).
Discussion
Value of Deep Sequencing Data
The rat is widely used as a model of heart disease and the
importance of miRNAs in heart disease is by now well recognised.
Therefore it is important to know as much as possible about
miRNA expression in the rat heart. Deep sequencing yields
information over and above that which can be obtained from
microarrays or qPCR, in that the miRNAs that can be detected
are not pre-designed into the method. Thus it provides the ability
Table 3. Epicardial/endocardial differential expression of unique sequences ($ 62 fold difference for miRs of $100 mean
normalised reads detected in either layer). %P,0.05 Baggerleys multiple comparison test.
Unique sequences Epi-cardium
Endo-
cardium
RPMM RPMM
Sequence miR name (type) Fold change Mean SEM Mean SEM
TACCCTGTAGAACCGAATTTG rno-mir-10b(P) 22.99 140.45 22.37 46.95 18.79
CTGGACGCGAGCCGGGCCCTT mmu-mir-5115(MSupV) 22.82 753.60 405.10 267.59 109.66
TACCCTGTAGAACCGAATTTGT rno-mir-10b(MSub/Sup) 22.54 2108.85 325.91 829.98 294.94
ATCCCACTTCTGACACCA bta-mir-2478(MSub) 22.45% 196.81 33.86 80.26 6.23
CCGCGTCGGCGGTTCCC nlo-mir-125(PV) 22.43 138.79 42.98 57.12 25.49
ACCCTGTAGAACCGAATTTGT rno-mir-10b(MSub/Sup) 22.42 119.77 21.71 49.43 15.33
TACCCTGTAGATCCGAATTTGA rno-mir-10a(MSubV) 22.22 325.04 20.21 146.52 55.43
CTGGACGCGAGCCGGGCCCTTCCC mmu-mir-5115(PV) 22.21 147.76 43.14 67.01 26.00
TCGTACCGTGAGTAATAATGC rno-mir-126(MSub) 22.17 821.18 347.35 378.83 99.04
TACCACAGGGTAGAACCACGGAA rno-mir-140(M*SupV) 22.16 348.57 66.62 161.25 22.11
ACCCTGTAGATCCGAATTTG rno-mir-10a(MSub) 22.14 272.77 37.62 127.17 50.55
ACCCTGTAGATCCGAATTTGT rno-mir-10a(MSub) 22.11 1779.84 246.64 842.11 327.87
CTGGACGCGAGCCGGGC mmu-mir-5115(MSubV) 22.10 508.53 119.83 241.60 100.94
TACCCTGTAGAACCGAATTTGTG rno-mir-10b(MSub/Sup) 22.09 192.96 12.82 92.16 32.52
TACCCTGTAGATCCGAATTT rno-mir-10a(P) 22.08 349.57 32.37 168.25 69.42
CTGGACGCGAGCCGGGCCCTTCC mmu-mir-5115(PV) 22.05 188.96 62.04 92.07 34.57
CTGGACGCGAGCCGGGCCCTTC mmu-mir-5115(MSupV) 22.04 775.70 233.89 380.53 157.79
AACCCGTAGATCCGAACTTGTGA rno-mir-100(MSupV) 22.01 768.45 357.07 382.85 189.43
TGTAAACATCCTCGACTGGAAGCG rno-mir-30a(MSupV) 2.06 118.32 23.96 243.52 139.23
TCCTGTACTGAGCTGCCCCGG bta-mir-486(MSubV) 2.39 133.14 28.86 318.16 181.42
GGGGGGCCCAAGTCCTTCTGATCGAGGCCC mmu-mir-5105(P) 2.93 73.61 16.57 215.65 93.91
CATTCAACGCTGTCGGTGAGT rno-mir-181a-2//mir-181a-
1(MSub)
40.70 6.08 0.93 247.35 243.97
CATTCAACGCTGTCGGTGAG rno-mir-181a-2//mir-181a-
1(MSub)
63.29 2.65 0.93 167.78 165.76
doi:10.1371/journal.pone.0065809.t003
Figure 10. Transmural miRNA expression gradients. Taqman
small RNA assays and TaqMan gene expression assays were performed
on epicardial and endocardial samples from rat hearts. Endocardial/
epicardial expression ratios were determined by analysis of Ct values
using REST 2009. The reference genes utilised were miRNAs with stable
expression across samples according to BestKeeper: miR-22, miR-30a,
miR-30c, miR-30e and miR-100. The reference genes for IRX5 and FOXP2
were GAPDH, HPRT1 and 18s rRNA. Data are mean 6 SEM; n = 4 hearts
for miRNAs (n = 3 of these for IRX5 and FOXP2). *P,.05; **P,.01;
***P,.001.
doi:10.1371/journal.pone.0065809.g010
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to detect novel sequences, including novel miRNAs and novel
isomiRs of known miRNAs. This advantage is well illustrated in
the present study.
Our data provide some interesting comparisons with the few
previous next-generation sequencing studies in the heart. Linsen
et al. [88] analysed rat heart using the SOLiDTM platform (Life
Technologies) and detected 180 miRNAs in common with our
study. There were 206 miRNAs detected in the present study that
were not found in rat heart by Linsen et al. and 357 miRNAs
reported in heart by Linsen et al. did not appear in our data.
However of the top 20 miRs detected by Linsen et al., 10 were
also highly detected in the present study. More recently Vacchi-
Suzzi et al. [116] also investigated the expression of miRNA in rat
left ventricle by next generation sequencing using HiSeq in
conjunction with TruSeq Small RNA Sample Preparation Kits
(Illumina). Vacchi-Suzzi et al. identified 636 rno- and/or mmu-
miRs including expression of mmu-miR-486 as well as co-
incidence of 13 of their top 20 highest detected miRNAs with
the present study. In the 3 rat studies 5 common miRNAs were
highly detected; rno-miR-26a, 30a, 30c, 30d & 30e.
In mouse heart 3 groups have investigated the miRNA
expression profile ([61,117,118] using next generation technologies
(Illumina, HiSeq 2000 and SOLiDTM platforms respectively). Of
the Top 20 miRNAs detected in each mouse study 6 were detected
in all 3 (mmu-miR-1, 126, 378, 26a, 125b & 133a). Thirteen of the
top 20 most frequently detected miRNAs in our data were also in
the top 20 of Rao et al.’s data [117], while 7 were also highly
detected in the Humphreys et al. study [61] and 12 were also
highly detected by Yang et al. [118]. The differences between
studies are likely attributable to the combined effects of different
species, tissue types (left ventricular wall vs whole heart),
sequencing technologies and data analysis parameters. Addition-
ally, given that the myocardium is not composed solely of
cardiomyocytes it is unlikely that these profiles are the product of
only this cell type; indeed Humphreys et al. identified 143
miRNAs which were expressed in either mouse left ventricular
or HL-1 cell samples but not in both [61]. As the mid-myocardium
(as used in the present study) also contains fibroblasts and vascular
endothelial cells, the contribution of these cell types to the
expression of miRNA needs to be considered; miR-21 (which we
detected as 30th highest) has been shown to be expressed up to 4-
fold higher in cardiac fibroblasts than myocytes [119] as well as
being highly detected in various vascular beds [54,55,120].
However as some miRNAs are known to be highly exported
Figure 11. Pathway analysis of MAP Kinase signaling (Kegg pathway). Highlighted genes are targets predicted by 2 or more algorithms of
the top 16 highest detected miRNAs (boxed in red; P = 1.8661026; 75 targets) showing overlap with genes expressed in the heart (highlighted;
expression data 9 SD rat left ventricular myocardium samples from 2 microarray experiments, (GSE6943; GSM160095–100 & GSE6880; GSM158589–91;
http://www.ncbi.nlm.nih.gov/gds).
doi:10.1371/journal.pone.0065809.g011
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[121,122], especially in disease states [5], the cellular origin of the
sequence may be of less importance than where they are
functionally active.
IsomiR Expression
Variability at the 59 end is likely to have a significant effect on
targeting because nts 2–8 form the seed region of the miRNA,
which has a considerable contribution to target determination [1].
Therefore the ability to detect isomiRs and distinguish them from
canonical miRNAs will enhance our understanding of the role of
miRNAs in health and disease. A good case in point is miR-133a,
of which more than half of the reads in our dataset were of a 59
variant isomiR (miR-133a(v)). Furthermore there is evidence from
miRBase for a similar proportion of miR-133a(v) vs miR-133a
expression in human. Since miR-133a is enriched in the heart and
dysregulated in heart disease [123–128], some changes in gene
expression in heart disease may be attributable to changes in miR-
133a(v). Genes predicted by DIANA-microT v3.0 to be targets of
miR-133a(v) but not canonical miR-133a include gelsolin and
KCNIP2 (KChIP2). Gelsolin is upregulated and promotes
apoptosis in cardiomyopathy [129]. If a substantial proportion of
all miR-133a isomiRs expressed in normal myocardium is miR-
133a(v) (as suggested by our data) then the downregulation of this
variant could contribute to the upregulation of gelsolin in heart
disease. A precedent for the possibility of miR-133a isomiR-
specific targeting has already been established [61]. Additionally,
KCNIP2 (an accessory protein that modulates several cardiac ion
channels and is involved in cardiac arrhythmia and heart failure
[130]) was downregulated by overexpression of a miR-133a
genomic precursor in mouse heart [131]. This was a surprising
finding because KCNIP2 is not a predicted target of miR-133a. It
is plausible that KCNIP2 was downregulated by miR-133a(v) if a
substantial proportion of the genomic precursor were processed to
form this isomiR.
IsomiRs with variations at the 39 end are less likely to differ in
terms of genes targeted because they do not alter the seed region.
However, 39 variation may affect certain target sites which rely on
complementarity at the 39 end, with potentially important
physiological consequences.
Novel Rat miRNAs and miRNA Genes
The importance of miR-1 in the heart is by now well recognised
[132]. Manipulation of miR-1 expression in the rat heart may be a
useful strategy for further investigating the physiological role of
miR-1. However, such studies could have been confounded by the
unknown existence of a second miR-1 gene. Our discovery of the
second gene is therefore critical for miR-1 expression studies in the
rat.
The putative novel miRNA reported in Fig. 8 has potential
implications for the expression of its target genes. DIANA-microT
v3.0 predicts 25 target sites in 7 genes for this miRNA sequence.
The putative target genes are ADAMTS13 (von Willebrand
factor-cleaving protease), SLC6A3 (Sodium-dependent dopamine
transporter), PCNT (Pericentrin), MBD3 (Methyl-CpG-binding
domain protein 3), ICOSLG (ICOS ligand precursor (B7 homolog
2)), FOXK2 (Forkhead box protein K2), and FOXK1 (Forkhead
box protein K1).
Small et al. [72] reported enrichment of miR-486 in cardiac
and skeletal muscle, and presented evidence for miR-486 as a
downstream mediator of the actions of serum response factor,
myocardin-related transcription factor-A and MyoD in muscle
cells and a potential modulator of PI3K/Akt signalling in rat
neonatal cardiomyocytes. Despite the likely importance of this
miRNA in rat muscle, rat miR-486 does not appear in the current
version of miRBase. This is presumably because the complete
miR-486 gene is not in the rat genome database. We used PCR to
read into this gap and determined the sequence of the pre-miR
(Fig. 9). This information should be useful for future studies of
miR-486 in rat models.
Transmural Expression Gradients
TargetScan 6.2 predicts 307 conserved targets for hsa-miR-21,
56 for hsa-miR-99b and 154 for hsa-miR-486-5p. FOXP2 is a
predicted target of miR-21; its expression is higher in epicardium
than endocardium [112] (Fig. 10), which is the opposite to the
gradient for miR-21 expression. This is consistent with miR-21
influencing transmural FOXP2 expression.
Calcineurin Aa (PPP3CA) is a predicted target of miR-21 and
miR-99b (TargetScan 6.2) and is expressed more in epicardium
than endocardium [113]. Calcineurin is a calmodulin-activated
serine/threonine protein phosphatase that mediates cardiac
hypertrophy progressing to heart failure [133] and electrical
remodelling [134]. In relation to left ventricular transmural
physiology, calcineurin downregulates expression of the Na+
channel Nav1.5 (SCN5A) and the gap junction proteins Cx40
(GJA5) and Cx43 (GJA1) [135], all of which are expressed in a
transmural gradient opposite to that of calcineurin Aa [100,112–
114]. Expression of the K+ channel Kv4.2 (KCND2) [136], the
sarcoplasmic reticulum Ca2+ pump SERCA2 (ATP2A2) [137] and
the Na+-Ca2+ exchanger NCX1 (SLC8A1) [137] is upregulated by
calcineurin, and the transmural expression pattern of these genes
parallels that of calcineurin [112,113]. Thus, at the level of gene
expression, there are consistencies that point toward a role of
calcineurin Aa in determining transmural gradients in cardiac
physiology. Nevertheless there may be non-transcriptional effects
that make the picture more complicated. Calcineurin phosphatase
activity is actually higher in endocardium than epicardium,
secondary to higher intracellular [Ca2+] [138]. Calcineurin may
have non-transcriptional inhibitory effects on SERCA2 [139] and
NCX1 [140,141] activity. The fast transient outward potassium
current (Ito,f) was increased by overexpression of constitutively
active calcineurin in cultured neonatal rat ventricular myocytes
[136] but reduced in calcineurin-overexpressing transgenic (TG)
mice [142]. The b isoform of calcineurin A is also expressed in
heart, uniformly across the left ventricular wall [138]. The relative
importance of the two isoforms is not clear. Inactivation of the
calcineurin Ab gene in mice caused an 80% decrease in
calcineurin enzymatic activity in the heart [143], suggesting that
Ab is the dominant calcineurin A isoform. On the other hand,
silencing of calcineurin Aa was more effective at reducing
SERCA2 expression than calcineurin Ab silencing in neonatal
rat cardiomyocytes [137]. Thus a role for miR-21 and/or miR-
99b in influencing transmural physiology is an intriguing
possibility but requires further study. It should also be mentioned
that the determination of transmural calcineurin Aa expression
was made in myocardial samples containing all cell types [113].
The above discussion pertains to cardiomyocytes but a transmural
expression gradient in other cell types cannot be excluded. miR-21
is abundant in cardiac fibroblasts [119], in which calcineurin may
be involved in regulating cell proliferation [144,145]. miR-21 is
enriched in endothelial cells [54,55,120], in which it mediates the
endothelial-to-mesenchymal transition [146] and angiogenesis
[147,148]. Enrichment of miR-99b was found in cardiac valves
[116], although there is no available evidence for a role of miR-
99b in valve disease.
NCX1 (SLC8A1) is important for cardiomyocyte Ca2+ extru-
sion. Its higher expression in epicardium vs endocardium [113] is
consistent with high endocardial intracellular [Ca2+] [138]. NCX1
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is a predicted target of miR-486 (TargetScan 6.2), which we found
to be higher in endocardium than epicardium (Fig. 10). Therefore
miR-486 could conceivably influence transmural differences in
intracellular Ca2+ handling.
IRX5 is a predicted target of miR-486, as discussed above.
IRX5 negatively regulates Kv4.2 K
+ channel expression, and the
IRX5 transmural expression gradient (higher in endocardium)
[112] (Fig. 10) is responsible for the expression gradient (higher in
epicardium) of Kv4.2 in the heart [76,77]. miR-486 may be able
to influence IRX5 expression but its own expression gradient tends
in the opposite direction for it to be responsible for the transmural
gradient of IRX5.
DIANA-microT v3.0 predicts 147 targets in 85 genes for the
most abundant rno-miR-10b isomiR (Fig. S2). Among these, the
transcription factor TBX5 is expressed in a transmural gradient
that changes with heart development [149].
Signalling Pathways
Within the Ubiquitin-mediated Proteolysis pathway the E1
enzyme UBLE1A and 14 of the 22 heart-expressed E2 enzymes
are predicted to be targeted by the 16 most highly expressed
miRNAs. Six of the 11 heart-expressed HECT type E3 enzymes, 3
out of 5 heart expressed U-box type E3 enzymes, 6 of 13 heart
expressed single RING-finger type E3 enzymes and 10 of 36 heart
expressed proteins within the multi subunit RING-finger type E3
complex are predicted targets. Recent studies have described how
ubiquitination in the heart is upregulated in common cardiac
diseases, including cardiac hypertrophy, heart failure, ischemia-
reperfusion injury, and diabetes (for review see [150]). The
overwhelming nature of the predicted targeting of the Ubiquitin-
mediated Proteolysis Pathway suggested by the expression profile
of our samples may reflect the importance of keeping this
mechanism under tight control in normal tissue.
Within the MAP Kinase pathway 55 of the 98 heart expressed
gene families (representing a total of 75 targets in 151 heart genes)
were predicted as potential targets (Fig. 11). Interestingly the Ras
gene family within this pathway was predicted to be targeted by 14
of the top 16 highest detected miRNAs; this family of genes as a
part of the Ras/Raf-1/MEK/ERK cascade is generally regarded
as playing a highly significant role in cardiac hypertrophy,
myocardial cell death and myocardial remodelling [151].
Another highly targeted pathway, Wnt signalling, which is
required for basic developmental processes such as control of
asymmetrical cell division, remodelling of the cytoskeleton and cell
adhesion [152,153] is likely to be of importance in the heart
especially in relation to the Wnt5 receptor, as Frizzled, and
downstream proteins PLC, CAMKII and Calcineurin are all
implicated in NFAT transcriptional changes associated with
hypertrophy [154,155]. All of our top 16 highest detected miRNAs
are predicted to target at least one of the genes encoding proteins
in the Wnt5 pathway.
Conclusion
We have used deep sequencing to measure miRNA expression
across the left ventricular wall of the adult rat heart. This has
highlighted the complexity of the in vivo miRNA profile, as
suggested by previous studies of cardiomyocyte cells [61]. Many
miRNAs not previously reported in rat were detected and for each
miRNA a range of isomiRs was present. Thorough characterisa-
tion of the normal pattern of miRNA expression is an important
basis from which to study the role of miRNAs in regulating gene
expression in the heart. Whilst transmural expression was uniform
for most miRNAs, the gradients found for several miRNAs are
intriguing and suggest potentially important roles in heart
physiology.
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